88IV - PR Newswire Asia's news - Health Care/Hospital


Siemens Healthineers Receives Frost & Sullivan's 2025 North America Company of the Year Award for Excellence in Advanced Visualization Applications Recognized for delivering diagnostic innovation, workflow efficiency, and enterprise imaging leadership through advanced visualization solutions ... 2025-07-28T Computer Software Computer/Electronics Health Care/Hospital Medical Equipment
XellSmart Completed World's First Patient Dosing in its Registrational Clinical trial for iPSC-derived Subtype-specific Neural Cell Therapy for Spinal Cord Injury SUZHOU, China , July 28, 2025 /PRNewswire/ -- XellSmart Biopharmaceutical (Suzhou/ Shanghai ) Co., Ltd. achieved a significant milestone in its "world's first" China NMPA & US ... 2025-07-28T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
World's First Engineered Exosome for Hair Growth & Localized Fat Reduction Secure INCI Designation: ImmVira Accelerates Access to Billion-Dollar Aging-related Market SUZHOU, China , July 28, 2025 /PRNewswire/ -- ImmVira Group ("ImmVira" or the "Company")recently announced that its engineered exosome products MVR-EX104 ("EX104", ... 2025-07-28T Biotechnology Cosmetics & Personal Care Health Care/Hospital Household/Consumer/Cosmetics
Alamar Biosciences Showcases Pioneering Brain-Derived pTau Data at the Alzheimer's Association International Conference (AAIC) Groundbreaking Insights into Neurodegenerative Disease Biomarkers to be Unveiled through 30+ Posters and Presentations at International Meeting ... 2025-07-28T Biotechnology Health Care/Hospital Medical/Pharmaceuticals Trade show news
Herbalgy x TEEMTONEfai Make a Groundbreaking Crossover Debut Cool Vibes to Welcome Herbalgy Trophy A Summer Cool-Off : Exclusive Mint Gelato x Icy Touch-Cool ... 2025-07-28T Food/Beverages Health Care/Hospital Retail
Antengene Announces XPOVIO® Approved in China for the Second-Line Treatment of Multiple Myeloma, Marking the Third Approved Indication of the Drug - This approval for XPOVIO ® in combination with bortezomib and dexamethasone (XVd) for the treatment of adult patients with multiple myeloma (MM) who have received at least one prior therapy marks ... 2025-07-28T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Interventional Robot's RCT Research Published in JNIS, a Leading Journal in Neurointervention! SHANGHAI , July 28, 2025 /PRNewswire/ -- The multicenter, randomized controlled trial (RCT) results of the PANVIS-A® NeuroInterventional Robotic System —led by Professor Liu Jianmin (Changhai ... 2025-07-28T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Embolx Launches Sniper G3: Revolutionizing Embolization with Enhanced Efficiency, Ease of Use, and Extended Shelf Life SUNNYVALE, Calif. , July 28, 2025 /PRNewswire/ -- Embolx, a leader in advanced microcatheters for targeted embolization procedures, today announced the release of its next-generation Sniper G3 Balloon ... 2025-07-28T Computer/Electronics Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Caliway Announces FDA Clearance of IND Application for CBL-514 to Proceed with SUPREME-01, the First Global Pivotal Phase 3 Study for Reducing Abdominal Subcutaneous Fat CBL-514, Caliway's first-in-class lipolysis drug candidate, has been granted clearance from the U.S. FDA to proceed with SUPREME-01, a global, multicenter, pivotal Phase 3 study. Subject recruitment is ... 2025-07-28T Health Care/Hospital Medical/Pharmaceuticals
Successful Completion of First CRS with HIPEC on a 60-year-old Woman with Advanced Peritoneal Carcinomatosis KOLKATA, India , July 28, 2025 /PRNewswire/ -- In a landmark achievement, a 60-year-old woman with advanced primary peritoneal carcinomatosis was successfully treated with Cytoreductive Surgery (CRS) ... 2025-07-28T Computer/Electronics Health Care/Hospital Medical Equipment Medical/Pharmaceuticals

PR Newswire Asia's news > Health Care/Hospital